| Purity | Size | Price(USD) | Lead Time | Quantity |
|---|---|---|---|---|
| 95% | 100mg | 306.0 | 1~3 weeks | |
| 95% | 250mg | 447.0 | 1~3 weeks | |
| 95% | 500mg | 805.0 | 1~3 weeks | |
| 95% | 1g | 1058.0 | 1~3 weeks | |
| 95% | 2.5g | 1905.0 | 1~3 weeks | |
| 95% | 5g | 2965.0 | 1~3 weeks | |
| 95% | 10g | 4500.0 | 1~3 weeks |
| Cat. No. | M226535 | CAS No. | 1334148-13-8 |
| Chemical Name | 7-Fluoro-1-methyl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine | MDL No. | |
| Molecular Weight | 180.22 | Molecular Formula | C10H13FN2 |
| Boiling Point | Storage | ||
| Description | 7-Fluoro-1-methyl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine is a compound of Heterocyclic Building Blocks research chemicals for sale. Its CAS No. is 1334148-13-8, molecular formula is C10H13FN2 and its molecular weight is 180.22 g/mol. The purity is usually 95%. Moldb provide CAS No.1334148-13-8, 7-Fluoro-1-methyl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine, 95% and document regarding 7-Fluoro-1-methyl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine, C10H13FN2, including NMR, HPLC, LC-MS and more. | ||
| Signal Word: | UN# | ||
| GHS Pictogram | Class | ||
| Hazard Statements | Packing Group | ||
| Precautionary Statements | |||
* For research and development use only. Not for human or other use.
